本页面由Tiger Trade Technology Pte. Ltd.提供服务

Champions Oncology, Inc.

6.04
-0.0650-1.07%
盘后6.040.00000.00%16:10 EDT
成交量:1,425.00
成交额:8,641.59
市值:8,380.40万
市盈率:-35.51
高:6.08
开:5.98
低:5.98
收:6.10
52周最高:9.63
52周最低:5.50
股本:1,388.63万
流通股本:518.91万
量比:0.15
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):0.3300
净资产收益率:-47.59%
总资产收益率:-4.70%
市净率:19.57
市盈率(LYR):18.29

数据加载中...

2022/12/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/20

重要事件披露

8-K - Current report
2022/09/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/07/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/21

重要事件披露

8-K - Current report
2022/03/15

重要事件披露

8-K - Current report
2022/03/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/13

重要事件披露

8-K - Current report
2021/12/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/07/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals